Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the quarter ended June 30, 2013.
•Worldwide sales were $107.0 million, a 11.5% increase from the second quarter of 2012
•Net income was $7.4 million or $0.08 per diluted share; Non-GAAP diluted EPS was $0.21
Help employers find you! Check out all the jobs and post your resume.
